Paper28036044
Immuno-PET for Clinical Theranostic Approaches.
Bailly C and 10 others. Int J Mol Sci, 2016. Cited by 55 papers, by iCite.
Cite this record
ConductScience Library. Immuno-PET for Clinical Theranostic Approaches. Papers, record 28036044. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28036044
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Neoplasms | Major topic |
| Positron-Emission Tomography | Major topic |
| Radiopharmaceuticals | Major topic |
| Animals | |
| Humans |
Source PubMed
References80
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23495938 | Nanobodies: natural single-domain antibodies. | Annu Rev Biochem | 2013 | https://conductscience.org/library/papers/23495938 | PubMed |
| 2 | 19596702 | Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer. | Ann Oncol | 2009 | https://conductscience.org/library/papers/19596702 | PubMed |
| 3 | 16187937 | Engineering of monoclonal antibodies and antibody-based fusion proteins: successes and challenges. | Expert Opin Biol Ther | 2005 | https://conductscience.org/library/papers/16187937 | PubMed |
| 4 | 24859229 | Antibodies directed against receptor tyrosine kinases: current and future strategies to fight cancer. | MAbs | 2014 | https://conductscience.org/library/papers/24859229 | PubMed |
| 5 | 17921028 | Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view. | Nucl Med Biol | 2007 | https://conductscience.org/library/papers/17921028 | PubMed |
| 6 | 16585157 | Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. | Cancer Res | 2006 | https://conductscience.org/library/papers/16585157 | PubMed |
| 7 | 25143071 | ⁸⁹Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer. | Eur J Nucl Med Mol Imaging | 2014 | https://conductscience.org/library/papers/25143071 | PubMed |
| 8 | 11722986 | Immunotherapy of Non-Hodgkin's lymphomas. | Hematology Am Soc Hematol Educ Program | 2001 | https://conductscience.org/library/papers/11722986 | PubMed |
| 9 | 14988743 | Monoclonal antibodies in human cancer. | Drugs Today (Barc) | 2003 | https://conductscience.org/library/papers/14988743 | PubMed |
| 10 | 27230928 | Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and 68Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human Trial. | J Nucl Med | 2016 | https://conductscience.org/library/papers/27230928 | PubMed |
| 11 | 24643780 | Predictive patient-specific dosimetry and individualized dosing of pretargeted radioimmunotherapy in patients with advanced colorectal cancer. | Eur J Nucl Med Mol Imaging | 2014 | https://conductscience.org/library/papers/24643780 | PubMed |
| 12 | 23908265 | Designing the magic bullet? The advancement of immuno-PET into clinical use. | J Nucl Med | 2013 | https://conductscience.org/library/papers/23908265 | PubMed |
| 13 | 19443594 | A novel method of 18F radiolabeling for PET. | J Nucl Med | 2009 | https://conductscience.org/library/papers/19443594 | PubMed |
| 14 | 25647074 | Radiopharmaceuticals as probes to characterize tumour tissue. | Eur J Nucl Med Mol Imaging | 2015 | https://conductscience.org/library/papers/25647074 | PubMed |
| 15 | 16530813 | Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance. | Acta Histochem | 2006 | https://conductscience.org/library/papers/16530813 | PubMed |
| 16 | 9831223 | ProstaScint scan may enhance identification of prostate cancer recurrences after prostatectomy, radiation, or hormone therapy: analysis of 136 scans of 100 patients. | Prostate | 1998 | https://conductscience.org/library/papers/9831223 | PubMed |
| 17 | 16611412 | The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors. | Neoplasia | 2006 | https://conductscience.org/library/papers/16611412 | PubMed |
| 18 | 23213092 | Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial. | J Clin Oncol | 2013 | https://conductscience.org/library/papers/23213092 | PubMed |
| 19 | 25216864 | Discordances in ER, PR and HER2 receptors between primary and recurrent/metastatic lesions and their impact on survival in breast cancer patients. | Med Oncol | 2014 | https://conductscience.org/library/papers/25216864 | PubMed |
| 20 | 23590171 | PET imaging in prostate cancer: focus on prostate-specific membrane antigen. | Curr Top Med Chem | 2013 | https://conductscience.org/library/papers/23590171 | PubMed |
Cited by44
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42588729 | Predicting Therapeutic Response to Antibody-Drug Conjugates Using Targeted PET Imaging: A Systematic Review. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42588729 | PubMed |
| 42540187 | Development and Preclinical Evaluation of a Novel EpCAM-Targeted 111In-Labeled Antibody for SPECT Imaging. | ACS Omega | 2026 | https://conductscience.org/library/papers/42540187 | PubMed |
| 41469159 | Construction and Evaluation of Guanylyl Cyclase C-Specific Antibody for Noninvasive Diagnosis and Targeted Therapy of Colorectal Cancer. | J Nucl Med | 2026 | https://conductscience.org/library/papers/41469159 | PubMed |
| 40459707 | Augmentation of [18F]-C-SNAT4 PET imaging of apoptosis after radiotherapy using a cold mixing strategy. | EJNMMI Res | 2025 | https://conductscience.org/library/papers/40459707 | PubMed |
| 39858014 | Nuclear Medicine and Molecular Imaging in Urothelial Cancer: Current Status and Future Directions. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/39858014 | PubMed |
| 39540283 | Emerging Imaging Techniques for Atherosclerosis in Systemic Immune-Mediated Inflammatory Conditions. | Arterioscler Thromb Vasc Biol | 2025 | https://conductscience.org/library/papers/39540283 | PubMed |
| 39355220 | Advances and challenges in immunoPET methodology. | Front Nucl Med | 2024 | https://conductscience.org/library/papers/39355220 | PubMed |
| 39192059 | Development of 52Mn Labeled Trastuzumab for Extended Time Point PET Imaging of HER2. | Mol Imaging Biol | 2024 | https://conductscience.org/library/papers/39192059 | PubMed |
| 39065579 | Zirconium 89 and Copper 64 for ImmunoPET: From Antibody Bioconjugation and Radiolabeling to Molecular Imaging. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39065579 | PubMed |
| 38665417 | In Vivo Detection of Staphylococcus aureus Infections Using Radiolabeled Antibodies Specific for Bacterial Toxins. | Int J Biomed Imaging | 2024 | https://conductscience.org/library/papers/38665417 | PubMed |
| 37895958 | Development and Preclinical Evaluation of [68Ga]BMSH as a New Potent Positron Emission Tomography Tracer for Imaging Programmed Death-Ligand 1 Expression. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37895958 | PubMed |
| 37752092 | Application of interim PET-CT in first-line treatment decision-making for lymphoma. | J Zhejiang Univ Sci B | 2023 | https://conductscience.org/library/papers/37752092 | PubMed |
| 37298101 | Recent Advances in 64Cu/67Cu-Based Radiopharmaceuticals. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37298101 | PubMed |
| 37027345 | Dual-Peak Lorentzian CEST MRI for antiretroviral drug brain distribution. | NeuroImmune Pharm Ther | 2023 | https://conductscience.org/library/papers/37027345 | PubMed |
| 36591250 | Cysteine-specific 89Zr-labeled anti-CD25 IgG allows immuno-PET imaging of interleukin-2 receptor-α on T cell lymphomas. | Front Immunol | 2022 | https://conductscience.org/library/papers/36591250 | PubMed |
| 35393508 | Imaging immunity in patients with cancer using positron emission tomography. | NPJ Precis Oncol | 2022 | https://conductscience.org/library/papers/35393508 | PubMed |
| 35309962 | Development of Dual Receptor Enhanced Pre-Targeting Strategy-A Novel Promising Technology for Immuno-Positron Emission Tomography Imaging. | Adv Ther (Weinh) | 2021 | https://conductscience.org/library/papers/35309962 | PubMed |
| 34621145 | Preclinical Molecular PET-CT Imaging Targeting CDCP1 in Colorectal Cancer. | Contrast Media Mol Imaging | 2021 | https://conductscience.org/library/papers/34621145 | PubMed |
| 34361793 | IEDDA: An Attractive Bioorthogonal Reaction for Biomedical Applications. | Molecules | 2021 | https://conductscience.org/library/papers/34361793 | PubMed |
| 34026426 | CD38-Targeted Theranostics of Lymphoma with 89Zr/177Lu-Labeled Daratumumab. | Adv Sci (Weinh) | 2021 | https://conductscience.org/library/papers/34026426 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CA9 | 768 | PubTator's text mining | https://conductscience.org/library/genes/768 | NCBI Gene |
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| CEACAM3 | 1084 | PubTator's text mining | https://conductscience.org/library/genes/1084 | NCBI Gene |
| CP | 1356 | PubTator's text mining | https://conductscience.org/library/genes/1356 | NCBI Gene |
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| FOLH1 | 2346 | PubTator's text mining | https://conductscience.org/library/genes/2346 | NCBI Gene |
| KRT20 | 54474 | PubTator's text mining | https://conductscience.org/library/genes/54474 | NCBI Gene |
| PDCD1 | 5133 | PubTator's text mining | https://conductscience.org/library/genes/5133 | NCBI Gene |
| TF | 7018 | PubTator's text mining | https://conductscience.org/library/genes/7018 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28036044
GET https://conductscience.org/api/papers/v1/28036044/references?page=2